At Pack Expo, MG America to Debut Latest Cartoner from Cariba

Cariba C221 is an intermittent motion, side-load cartoner capable of producing 120 cartons per minute

MG America, the U.S. subsidiary of MG2 of Bologna, Italy and a leading supplier of processing and packaging equipment, will introduce to the North American market the latest cartoner from established pharma machinery provider Cariba at Pack Expo, October 23-26 in Chicago. At Booth W-15003, MG America will showcase the new Cariba C221 Cartoner, an intermittent motion horizontal model capable of producing up to 120 cartons/min.

With picking-arm enabled positive carton forming, the Cariba C2221 is suitable for pharmaceutical, nutraceutical and cosmetics application. The unit is available either with a manual feeding station or a variety of automatic product feeders. In either configuration, the Cariba C221 is compatible with a broad range of common primary packaging formats, including blister packs, round/shaped glass and plastic bottles, jars, soft tubes, flow packs, sachets, and stick packs.

Changeover is fast, and based mainly on adjustments rather than replacements. Tuck-in and hot-melt closures are available, with a combination of the two providing tamper evidence. Printing options include emboss, inkjet and laser coding, and the unit comes equipped with integrated barcode-reading capabilities.

The Cariba C2221’s balcony-style design ensures easy cleaning and maintenance, as well as separation between electrical and mechanical sections. Its lowered carton magazine, full servo assisted motions, controlled adjustable transportation and coated guides combine to eliminate marking on components.

The Cariba C221 can be customized with a variety of additional features, including extended carton magazines, pre-folded leaflets and booklet dispensers, leaflet folding units (GUK), serialization-ready external modules, and remote connectivity.

“In a pharmaceutical manufacturing landscape that increasingly demands functional flexibility, the Cariba C221 offers unsurpassed versatility in its cartoning class,” said Claudio Radossi, President of MG America. “We look forward to showcasing it, as well as several other packaging and processing solutions, at this year’s Pack Expo.”

Over more than 35 years of business, Cariba has developed an outstanding reputation for its wide range of machinery, which includes cartoners, closing machines, case packers and complete line solutions. Cariba serves a broad swath of packaging sectors, including pharmaceuticals, cosmetics, food, consumer electronics and household and cleaning products.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”